|Articles|June 26, 2011
Sulfonylurea monotherapy ups CVD risk vs. metformin in older diabetics
Older patients started on oral antidiabetic therapy with a sulfonylurea have significantly higher risk for cardiovascular disease (CVD) events than patients started on metformin.
Advertisement
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Medical Economics
1
‘Ghost’ physicians in Medicaid: Nearly 1 in 3 see no Medicaid patients
2
Investing in the nuclear power renaissance
3
Affordable drug advocates claim victory over pharmacy benefit managers in budget bill
4
Can virtual care be better than in-person care?
5